Mitux E

Barcode: 8935206007817

Acetylcysteine ....................................................... 100 mg
Excipients q.s....................................................... 1 sachet
(Orange-flavored powder, aspartame, betacarotene 20% DC, sunset yellow color, refined sugar, lactose).
PRESENTATION: Box of 24 sachets x 1.5 g.
ACTIONS: Mitux E containing the main active ingredient - Acetylcysteine, is a mucolytic agent, impacts on the gel phase of viscous mucus by the splitting of disulphide bonds in glycoproteins. The drug is used to reduce the viscosity of pulmonary sputum, thus facilitating expectoration. After oral administration, Acetylcysteine is rapidly absorbed from the gastrointestinal tract and obtains the top plasma concentration within 0.5 - 1 hour. Because of its particular affinity to pulmonary tissues and bronchial secretions, Acetylcysteine concentration is effectively reached in 3 hours.
Used as a mucolytic drug in the treatment of respiratory pathologies associated with condensed mucus condition e.g bronchitis, tracheobronchitis, acute and chronic bronchopneumonia, rhinitis, laryngitis, sinusitis, secretory otitis media.
CONTRAINDICATIONS: Hypersensitivity to Acetylcysteine. Children aged less than 2 years.
A history of asthma (the risk of bronchopastic reactivity occurring to all Acetylcysteine-containing drugs)
PRECAUTIONS: The drug should be use with careful watch in patients with the risk of asthma, when indicating Acetylcysteine to the individuals with a known history of allergy; in case of being bronchospam, a bronchial dilatation e.g Salbutamol or Ipratropium should be used, and stop Acetylcysteine immediately. Dilated sputum may occur abundantly in bronchus when treating with Acetylcysteine; therefore, it is required to suck sputum in patients with reduced ability to cough.
Pregnant women: There are no controlled data in human pregnancy. Acetylcysteine is only recommended for use during pregnancy when benefit outweighs risk.
Nursing mothers: There are no data on the excretion of acetylcysteine into human milk; however, caution should be exercised when administering acetylcysteine to nursing women.
Combination of the drugs of viscous mucus harmonization and antitussive, and/or dryness of mucous secretion is unreasonable.
ADVERSE EFFECTS: Commonly: nausea, vomiting.
Occasionally: drowsiness, headache, tinnitus, stomatitis, severe rhinorrhea, skin rash, urticaria.
Rarely: bronchopasm associated with systemic anaphylactic reaction, fever, tremble.
Inform your physician about any adverse effects occur during the treatment.
OVERDOSAGE: Symptoms following overdosage with acetylcysteine have been similar to those of anaphylactoid reactions, but they may be more severe. Hypotension appears to be especially prominent. Other features reported included respiratory insufficiency, hemolysis, hematopexis in the inner vessel, renal impairment. Fatality occurred in patient following overdosage with acetylcysteine while treating paracetamol poisoning. Treatment of overdosage depends on each symptom.
Children aged from 2 - 6 years: 2 sachets, twice daily.
Or as directed by the physician.
Read the directions carefully before use.
Consult the physician for more information.
Shelf-life: 36 months from the manufacturing date.
Storage conditions: Store in a dry place, not exceeding 30oC, protect from light.
Specifications: Manufacturer's.


There are yet no reviews for this product.